TP53 mutations, particularly in the DNA-binding domain spanning exons 5–8, results in the malfunctioning of DNA damage repair pathways and are the most frequently reported mutation in solid tumors, including breast cancer [29, 40]. This evidence concerns the gene TP53 and breast carcinoma.